Montgomery Community Media

Former U.S. Rep. John Delaney (D-Md. 6) is getting attention on Twitter for his idea for distributing a coronavirus vaccine, once it is made available. Delaney tweeted Friday, “Pay everyone $1500 to get vaccine[.] It is a stimulus check & big vaccine incentive rolled into one[.] Result: more people get vaccine, it saves lives, helps […]

Novavax, a vaccine development company in Gaithersburg, Md., released details for a $1.6 billion government contract for a COVID-19 vaccine on Nov. 11, according to NPR. The contract is part of the Trump Administration’s “Operation Warp Speed,” a program to make a vaccine available to the public in record time. Over the past several months, […]

The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials. The coronavirus pandemic has forced researchers to condense years of research and testing into a shorter time frame, with the goal to produce a safe […]

The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August 4, 2020 In early July, Novavax received $1.6 billion in funding as part of the federal government’s Operation Warp Speed, an initiative aiming to accelerate […]

The Tokyo-based Fujifilm Diosynth Biotechnologies joined other companies Monday in helping Gaithersburg’s Novavax produce and distribute the first batch of a potential COVID-19 vaccine to be used in clinical trials.  Novavax will be making its Covid-19 vaccine candidate with help Fujifilm Diosynth Biotechnologies, part of the $1.6 billion the Gaithersburg biotech secured from the federal […]

The Federal government recently awarded Gaithersburg-based biotech company Novavax 1.6 billion in funding to develop and distribute 100 million COVID-19 vaccines as early as the end of this year. County Cable Montgomery’s Susan Kenedy spoke with Jim Young, the Novavax Chairman of the Board, about the work being done at Novavax. He explained why the […]

A vaccine development company headquartered in Gaithersburg is starting clinical trials for a potential COVID-19 vaccine.  Novavax will administer the trials for vaccine candidate NVX‑CoV2373 in two phases, a statement from the company says. Phase 1 will test 131 people in Australia for immune response and safety. Results are expected in July. “Administering our vaccine […]

Washington Metropolitan Area Transit Authority released its multi-phased COVID-19 recovery plan Monday, indicating it may not return to its normal operations until Spring 2021. On Saturday, Paul Wiedefeld, general manager and CEO of WMATA, penned an op-ed in the Washington Post, saying, “Until a vaccine is available, our customer experience can’t be what it was […]

A local bio-technology company has found a coronavirus vaccine candidate, and the first in-human trial is expected to begin in May. Novavax, which is located in Gaithersburg, develops next-generation vaccines for serious infectious diseases. Officials say they will be using NVX-CoV2373, which is described as a stable, prefusion protein made using Novavax’s proprietary nanoparticle technology. “Our scientists […]